Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process
Open accessAbstract
-Dimethyltryptamine (DMT, one of the alkaloids in Ayahuasca) activates sigma 1 receptor (SIGMAR1) and others. SIGMAR1 is a multi-faceted stress-responsive receptor which promotes cell survival, neuroprotection, neuroplasticity, and neuroimmunomodulation. Simultaneously, monoamine oxidase inhibitors (MAOIs) also present in Ayahuasca prevent the degradation of DMT. One peculiarity of SIGMAR1 activation and MAOI activity is the reversal of mnemonic deficits in pre-clinical models. Since traumatic memories in post-traumatic stress disorder (PTSD) are often characterised by "repression" and PTSD patients ingesting Ayahuasca report the retrieval of such memories, it cannot be excluded that DMT-mediated SIGMAR1 activation and the concomitant MAOIs effects during Ayahuasca ingestion might mediate such "anti-amnesic" process. Here I hypothesise that Ayahuasca, via hyperactivation of trauma and emotional memory-related centres, and via its concomitant SIGMAR1- and MAOIs- induced anti-amnesic effects, facilitates the retrieval of traumatic memories, in turn making them labile (destabilised). As Ayahuasca alkaloids enhance synaptic plasticity, increase neurogenesis and boost dopaminergic neurotransmission, and those processes are involved in memory reconsolidation and fear extinction, the fear response triggered by the memory can be reprogramed and/or extinguished. Subsequently, the memory is stored with this updated significance. To date, it is unclear if new memories replace, co-exist with or bypass old ones. Although the mechanisms involved in memory are still debated, they seem to require the involvement of cellular and molecular events, such as reorganisation of homo and heteroreceptor complexes at the synapse, synaptic plasticity, and epigenetic re-modulation of gene expression. Since SIGMAR1 mobilises synaptic receptor, boosts synaptic plasticity and modulates epigenetic processes, such effects might be involved in the reported healing of traumatic memories in PTSD patients. If this theory proves to be true, Ayahuasca could come to represent the only standing pharmacological treatment which targets traumatic memories in PTSD. Lastly, since SIGMAR1 activation triggers both epigenetic and immunomodulatory programmes, the mechanism here presented could help understanding and treating other conditions in which the cellular memory is dysregulated, such as cancer, diabetes, autoimmune and neurodegenerative pathologies and substance addiction.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Activation of S1R by DMT has been suggested to stimulate synaptic plasticity in addition to 5-HT2AR-induced modulation and is likely responsible for ayahuasca's antidepressant effects.
“Activation of S1R by DMT has been suggested to stimulate synaptic plasticity in addition to 5-HT2AR-induced modulation and is likely responsible for ayahuasca's antidepressant effects (64, 102).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [102]
The Abstract (page unavailable) says DMT activates SIGMAR1 and that SIGMAR1 boosts synaptic plasticity; the Introduction also says DMT binds 5-HT2A receptors. But the paper does not identify DMT-driven SIGMAR1 plasticity as the likely cause of ayahuasca’s antidepressant effects. In ‘Ayahuasca Ingestion Modulates Neurotransmission’ (page unavailable), it says only that neurotransmission changes could be involved in those effects. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545 · see citing works
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
Bootman, M. D., Missiaen, L., Parys, J. B., SMEDT, H. D., & Casteels, R. (1995) · Biochemical Journal · doi:10.1042/bj3060445 · Cited by 5,120 · see citing works
Memory - A century of consolidation
McGaugh, J. L. (2000) · Science · doi:10.1126/science.287.5451.248 · Cited by 4,250 · see citing works
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917 · see citing works
Emotional processing in anterior cingulate and medial prefrontal cortex
Etkin, A., Egner, T., & Kalisch, R. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.11.004 · Cited by 3,059 · cited 3× · see citing works
“…that Ayahuasca creates a pattern of brain activity which is conducive to the recall and/or re-experiencing of traumatic memories, or memories that have a negative connotation (Phillips et al., 1998; Ullsperger et al., 2010; Etkin et al., 2011; Zhu et al., 2012; Tabei, 2015; Urgesi et al., 2016).”
BackgroundSynaptic Plasticity and Memory: An Evaluation of the Hypothesis
Martin, S. J., Grimwood, P. D., & Morris, R. G. M. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.649 · Cited by 2,794 · see citing works
Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval
Nader, K., Schafe, G. E., & Le Doux, J. E. (2000) · Nature · doi:10.1038/35021052 · Cited by 2,706 · see citing works
Epigenetics: A landscape takes shape
Goldberg, A. D., Allis, C. D., & Bernstein, E. (2007) · Cell · doi:10.1016/j.cell.2007.02.006 · Cited by 2,466 · see citing works
Mayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.675 · Cited by 2,416 · see citing works
Hayashi, T., & Su, T.-P. (2007) · Cell · doi:10.1016/j.cell.2007.08.036 · Cited by 1,826 · see citing works
Myers, K. M., & Davis, M. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001939 · Cited by 1,277 · see citing works
Preventing the return of fear in humans using reconsolidation update mechanisms
Schiller, D., Monfils, M.-H., Raio, C. M., Johnson, D. C., LeDoux, J. E., & Phelps, E. A. (2010) · Nature · doi:10.1038/nature08637 · Cited by 1,248 · see citing works
Amygdala, medial prefrontal cortex, and hippocampal function in PTSD
SHIN, L. M., RAUCH, S. L., & PITMAN, R. K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.007 · Cited by 1,203 · see citing works
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172 · see citing works
Cellular Memory and the Histone Code
Turner, B. M. (2002) · Cell · doi:10.1016/s0092-8674(02)01080-2 · Cited by 1,142 · see citing works
Purification, molecular cloning, and expression of the mammalian sigma1-binding site.
Hanner, M., Moebius, F. F., Flandorfer, A., Knaus, H. G., Striessnig, J., Kempner, E. S., & Glossmann, H. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.8072 · Cited by 906 · see citing works
Neural responses to facial and vocal expressions of fear and disgust
Phillips, M. L., Young, A. W., Scott, S. K., Calder, A., Andrew, C., Giampietro, V., Williams, S., Bullmore, E. T., Brammer, M. J., & Gray, J. A. (1998) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1998.0506 · Cited by 817 · see citing works
Traumatic stress: effects on the brain
Bremner, J. D. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/jbremner · Cited by 738 · see citing works
The synaptic plasticity and memory hypothesis: encoding, storage and persistence
Takeuchi, T., Duszkiewicz, A. J., & Morris, R. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0288 · Cited by 664 · see citing works
Bunzow, J. R., Sonders, M. S., Arttamangkul, S., Harrison, L. M., Zhang, G., Quigley, D. I., Darland, T., Suchland, K. L., Pasumamula, S., Kennedy, J. L., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1181 · Cited by 651 · see citing works
An Update on Memory Reconsolidation Updating
Lee, J. L. C., Nader, K., & Schiller, D. (2017) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2017.04.006 · Cited by 557 · see citing works
The Hallucinogen <i>N,N</i> -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
Fontanilla, D., Johannessen, M., Hajipour, A. R., Cozzi, N. V., Jackson, M. B., & Ruoho, A. E. (2009) · Science · doi:10.1126/science.1166127 · Cited by 535 · see citing works
Lanius, R. A., Williamson, P. C., Densmore, M., Boksman, K., Gupta, M. A., Neufeld, R. W., Gati, J. S., & Menon, R. S. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1920 · Cited by 521 · see citing works
Mayford, M., Siegelbaum, S. A., & Kandel, E. R. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005751 · Cited by 500 · see citing works
Sanches, R. F., de Lima Osório, F., dos Santos, R. G., Macedo, L. R. H., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A. S., & Hallak, J. E. C. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000436 · Cited by 466 · see citing works
Conscious perception of errors and its relation to the anterior insula
Ullsperger, M., Harsay, H. A., Wessel, J. R., & Ridderinkhof, K. R. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0261-1 · Cited by 463 · see citing works
Palhano-Fontes, F., Andrade, K. C., Tofoli, L. F., Santos, A. C., Crippa, J. A. S., Hallak, J. E. C., Ribeiro, S., & de Araujo, D. B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118143 · Cited by 454 · see citing works
Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049882 · Cited by 390 · see citing works
Aghajanian, G. K., & Marek, G. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01224-x · Cited by 376 · see citing works
Borroto‐Escuela, D. O., Carlsson, J., Ambrogini, P., Narváez, M., Wydra, K., Tarakanov, A. O., Li, X., Millón, C., Ferraro, L., Cuppini, R., et al. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00037 · Cited by 375 · see citing works
The history of the cholinergic hypothesis
Contestabile, A. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.044 · Cited by 373 · see citing works
Maguire, E. A., & Mummery, C. J. (1999) · Hippocampus · doi:10.1002/(sici)1098-1063(1999)9:1 · Cited by 362 · see citing works
Epigenetic Priming of Memory Updating during Reconsolidation to Attenuate Remote Fear Memories
Gräff, J., Joseph, N. F., Horn, M. E., Samiei, A., Meng, J., Seo, J., Rei, D., Bero, A. W., Phan, T. X., Wagner, F., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.020 · Cited by 357 · see citing works
The emerging field of epigenetics in neurodegeneration and neuroprotection
Hwang, J.-Y., Aromolaran, K. A., & Zukin, R. S. (2017) · Nature reviews. Neuroscience · doi:10.1038/nrn.2017.46 · Cited by 343 · see citing works
Different mechanisms of fear extinction dependent on length of time since fear acquisition
Myers, K. M., Ressler, K. J., & Davis, M. (2006) · Learning & Memory · doi:10.1101/lm.119806 · Cited by 334 · see citing works
What are memories made of? How Polycomb and Trithorax proteins mediate epigenetic memory
Steffen, P. A., & Ringrose, L. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3789 · Cited by 318 · see citing works
Phylogenetic Distribution of Fungal Sterols
Weete, J. D., Abril, M., & Blackwell, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010899 · Cited by 316 · see citing works
Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases
Paul, B., Barnes, S., Demark-Wahnefried, W., Morrow, C., Salvador, C., Skibola, C., & Tollefsbol, T. O. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0144-7 · Cited by 306 · see citing works
Vollenweider, F. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00108-0 · Cited by 305 · cited 2× · see citing works
“The authors suggested that, since psilocybin increases dopaminergic neurotransmission, and since drugs that increase dopamine availability are beneficial to fear extinction, psilocybin might be beneficial to fear extinction via enhancing dopaminergic neurotransmission (Aghajanian and Marek, 1999; Vollenweider et al.,…”
BackgroundPsychedelics and the Human Receptorome
Ray, T. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009019 · Cited by 300 · see citing works
Bremner, J. D. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830150070011 · Cited by 299 · see citing works
Memory formation, consolidation and transformation
Nadel, L., Hupbach, A., Gómez, R. L., & Newman-Smith, K. C. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.03.001 · Cited by 295 · see citing works
Maurice, T., Su, T., & Privat, A. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00405-3 · Cited by 291 · see citing works
Alberini, C. M., & LeDoux, J. E. (2013) · Current Biology · doi:10.1016/j.cub.2013.06.046 · Cited by 286 · see citing works
The Molecular Biology of Memory Storage: A Dialog Between Genes and Synapses
Kandel, E. R. (2004) · Bioscience Reports · doi:10.1007/s10540-005-2742-7 · Cited by 280 · see citing works
Greenberg, D. L., Rice, H. J., Cooper, J. J., Cabeza, R., Rubin, D. C., & LaBar, K. S. (2005) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2004.09.002 · Cited by 273 · see citing works
Memory formation under stress: Quantity and quality
Schwabe, L., Wolf, O. T., & Oitzl, M. S. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.11.015 · Cited by 268 · see citing works
Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning
Catlow, B. J., Song, S., Paredes, D. A., Kirstein, C. L., & Sanchez-Ramos, J. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3579-0 · Cited by 266 · see citing works
Cued and Contextual Fear Conditioning for Rodents
Rustay, N. R., Browman, K. E., & Curzon, P. (2008) · Frontiers in neuroscience · doi:10.1201/noe1420052343.ch2 · Cited by 254 · see citing works
The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization
Frecska, E., Bokor, P., & Winkelman, M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00035 · Cited by 242 · see citing works
Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant
Riba, J., Romero, S., Grasa, E., Mena, E., Carrió, I., & Barbanoj, M. J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0358-7 · Cited by 241 · see citing works
The IκB Kinase Regulates Chromatin Structure during Reconsolidation of Conditioned Fear Memories
Lubin, F. D., & Sweatt, J. D. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.039 · Cited by 234 · see citing works
Ayahuasca: pharmacology, neuroscience and therapeutic potential
Domínguez-Clavé, E., Soler, J., Elices, M., Pascual, J. C., Álvarez, E., de la Fuente Revenga, M., Friedlander, P., Feilding, A., & Riba, J. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.03.002 · Cited by 226 · see citing works
Epigenetics of posttraumatic stress disorder: current evidence, challenges, and future directions
Zannas, A. S., Provençal, N., & Binder, E. B. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.003 · Cited by 218 · see citing works
Epigenetics, cellular memory and gene regulation
Henikoff, S., & Greally, J. M. (2016) · Current Biology · doi:10.1016/j.cub.2016.06.011 · Cited by 215 · see citing works
Dopamine and extinction: A convergence of theory with fear and reward circuitry
Abraham, A. D., Neve, K., & Lattal, K. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.11.007 · Cited by 211 · see citing works
Yu, B., Becnel, J., Zerfaoui, M., Rohatgi, R., Boulares, A. H., & Nichols, C. D. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143461 · Cited by 211 · see citing works
Polycomb repression: from cellular memory to cellular proliferation and cancer
Jacobs, J. J. L., & van Lohuizen, M. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00052-5 · Cited by 209 · see citing works
Kourrich, S., Hayashi, T., Chuang, J., Tsai, S., Su, T., & Bonci, A. (2013) · Cell · doi:10.1016/j.cell.2012.12.004 · Cited by 195 · see citing works
Szabo, A., Kovacs, A., Frecska, E., & Rajnavolgyi, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106533 · Cited by 191 · see citing works
Morales-García, J. A., de la Fuente Revenga, M., Alonso-Gil, S., Rodríguez-Franco, M. I., Feilding, A., Perez-Castillo, A., & Riba, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-05407-9 · Cited by 175 · see citing works
The role of hippocampus in memory: A hypothesis
Teyler, T. J., & DiScenna, P. G. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90016-8 · Cited by 169 · see citing works
Reconsolidation of memory: A decade of debate
Besnard, A., Caboche, J., & Laroche, S. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.07.002 · Cited by 168 · see citing works
The role of the amygdala in the extinction of conditioned fear.
Barad, M., Gean, P., & Lutz, B. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.029 · Cited by 168 · see citing works
Demmerle, J., Koch, A. J., & Holaska, J. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.325308 · Cited by 168 · see citing works
Biology, Genetics, and Management of Ergot (Claviceps spp.) in Rye, Sorghum, and Pearl Millet
Miedaner, T., & Geiger, H. H. (2015) · Toxins · doi:10.3390/toxins7030659 · Cited by 164 · see citing works
Nichols, C. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00405-5 · Cited by 163 · see citing works
McDonald, A. J., & Mascagni, F. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00380-3 · Cited by 157 · cited 4× · see citing works
“Since CB1 receptors are enriched in the amygdala (one of the brain areas hyperactivated by Ayahuasca), and given that CB1 or NMDA agonists prevent fear expression during traumatic memory retrieval, this supports a role for Ayahuasca in the updating and reconsolidation of traumatic memories by modulating the fear respo…”
BackgroundInfluentialPlants of the Gods: Origins of Hallucinogenic Use
Brenan, J. P. M., Schultes, R. E., & Hofmann, A. (1980) · Kew Bulletin · doi:10.2307/4110029 · Cited by 154 · see citing works
Fortunato, J. J., Réus, G. Z., Kirsch, T. R., Stringari, R. B., Stertz, L., Kapczinski, F., Pinto, J. P., Hallak, J. E., Zuardi, A. W., Crippa, J. A., et al. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.07.021 · Cited by 150 · see citing works
Staniloiu, A., & Markowitsch, H. J. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70279-2 · Cited by 148 · see citing works
Post-traumatic stress disorder and declarative memory functioning: a review
Samuelson, K. W. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.2/ksamuelson · Cited by 148 · see citing works
Agonist Properties of N,N-Dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors
Smith, R. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00110-5 · Cited by 147 · see citing works
3,4-Methylenedioxymethamphetamine facilitates fear extinction learning
Young, M. B., Andero, R., Ressler, K. J., & Howell, L. L. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.138 · Cited by 141 · see citing works
Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT
Dakic, V., Minardi Nascimento, J., Costa Sartore, R., Maciel, R. D. M., de Araujo, D. B., Ribeiro, S., Martins-de-Souza, D., & Rehen, S. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-12779-5 · Cited by 134 · cited 2× · see citing works
“Significantly, the DMT analogue 5-methoxy-N,N-dimethyltryptamine as well as the synthetic psychedelic 2,5-Dimethoxy-4-iodoamphetamine downregulate this pathway, suggesting that DMT and Ayahuasca might present at least same degree of NFKB pathway modulation (Yu et al., 2008; Dakic et al., 2017).”
BackgroundIshikawa, M., Ishiwata, K., Ishii, K., Kimura, Y., Sakata, M., Naganawa, M., Oda, K., Miyatake, R., Fujisaki, M., Shimizu, E., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.001 · Cited by 132 · see citing works
Sigma-1 Receptor Chaperones and Diseases
Tsai, S., Hayashi, T., Mori, T., & Su, T. (2009) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524910909030184 · Cited by 130 · see citing works
Maddox, S. A., & Schafe, G. E. (2011) · Learning & Memory · doi:10.1101/lm.2243411 · Cited by 130 · see citing works
Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor
Fujimoto, M., Hayashi, T., Urfer, R., Mita, S., & Su, T.-P. (2012) · Synapse · doi:10.1002/syn.21549 · Cited by 124 · see citing works
Borroto‐Escuela, D. O., Agnati, L. F., Bechter, K., Jansson, A., Tarakanov, A. O., & Fuxé, K. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0183 · Cited by 121 · see citing works
Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors
Albizu, L., Holloway, T., González-Maeso, J., & Sealfon, S. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.023 · Cited by 121 · see citing works
Brand, M., Eggers, C., Reinhold, N., Fujiwara, E., Kessler, J., Heiss, W., & Markowitsch, H. J. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.03.008 · Cited by 120 · see citing works
Speth, J., Speth, C., Kaelen, M., Schloerscheidt, A. M., Feilding, A., Nutt, D., & Carhart-Harris, R. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116628430 · Cited by 118 · see citing works
Hetero-dimerization of serotonin 5-HT2A and dopamine D2 receptors
Łukasiewicz, S., Polit, A., Kędracka–Krok, S., Wędzony, K., Maćkowiak, M., & Dziedzicka‐Wasylewska, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.08.010 · Cited by 118 · see citing works
Bedard-Gilligan, M., & Zoellner, L. A. (2012) · Memory · doi:10.1080/09658211.2012.655747 · Cited by 116 · cited 1× · see citing works
“It has been suggested that this mechanisms might be relevant to PTSD via the phenomenon of “dissociative encoding”, the insufficient encoding of the trauma memory following peritraumatic dissociation which prevents future re-elaboration of the traumatic memory (Bedard-Gilligan and Zoellner, 2012).”
BackgroundTsai, S., Chuang, J., Tsai, M.-S., Wang, X.-F., Xi, Z., Hung, J., Chang, W., Bonci, A., & Su, T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518894112 · Cited by 115 · see citing works
Epigenetic mechanisms of memory formation and reconsolidation
Jarome, T. J., & Lubin, F. D. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2014.08.002 · Cited by 112 · see citing works
Frecska, E., Szabo, A., Winkelman, M. J., Luna, L. E., & McKenna, D. J. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1024-y · Cited by 109 · cited 1× · see citing works
“SIGMAR1 is a transmembrane protein with neuroprotective, neurotrophic, and immunomodulatory properties found in high concentrations in limbic areas of the human brain and in immune cells (Ishikawa et al., 2007; Fujimoto et al., 2012; Frecska et al., 2013; Szabo et al., 2014).”
BackgroundGazarini, L., Stern, C. A. J., Piornedo, R. R., Takahashi, R. N., & Bertoglio, L. J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu026 · Cited by 102 · see citing works
Vázquez, P. M., Cortés, R., & Artigas, F. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn204 · Cited by 102 · see citing works
Borroto‐Escuela, D. O., Romero‐Fernandez, W., Tarakanov, A. O., Marcellino, D. J., Ciruela, F., Agnati, L. F., & Fuxé, K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.110 · Cited by 98 · see citing works
Voltage-gated sodium channel modulation by σ-receptors in cardiac myocytes and heterologous systems
Johannessen, M., Ramachandran, S., Riemer, L., Ramos-Serrano, A., Ruoho, A. E., & Jackson, M. B. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00431.2008 · Cited by 97 · see citing works
TRPV1 channels and the progesterone receptor Sig-1R interact to regulate pain
Ortíz-Rentería, M., Juárez-Contreras, R., González‐Ramírez, R., Islas, L. D., Sierra-Ramírez, F., Llorente, I., Simon, S. A., Hiriart, M., Rosenbaum, T., & Morales‐Lázaro, S. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715972115 · Cited by 96 · see citing works
Borroto‐Escuela, D. O., Romero‐Fernandez, W., Narváez, M., Oflijan, J., Agnati, L. F., & Fuxé, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.11.104 · Cited by 88 · see citing works
Epigenetic mechanisms in fear conditioning: Implications for treating post-traumatic stress disorder
Kwapis, J. L., & Wood, M. A. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.08.005 · Cited by 87 · see citing works
Memory Repression: Brain Mechanisms underlying Dissociative Amnesia
Kikuchi, H., Fujii, T., Abe, N., Suzuki, M., Takagi, M., Mugikura, S., Takahashi, S., & Mori, E. (2009) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2009.21212 · Cited by 85 · see citing works
Nichols, C. D., Garcia, E. E., & Sanders-Bush, E. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00029-9 · Cited by 82 · see citing works
Platelet serotonin uptake sites increased in drinkers ofayahuasca
Callaway, J. C., Airaksinen, M. M., McKenna, D. J., Brito, G. S., & Grob, C. S. (1994) · Psychopharmacology · doi:10.1007/bf02245347 · Cited by 81 · see citing works
The anterior left inferior frontal gyrus contributes to semantic unification
Zhu, Z., Peter Hagoort, A., Zhang, J. X., Feng, G., Chen, H.-C., BASTIAANSEN, M. C. M., & Wang, S. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.02.036 · Cited by 77 · see citing works
van Rooij, S. J. H., Rademaker, A. R., Kennis, M., Vink, M., Kahn, R. S., & Geuze, E. (2014) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.130223 · Cited by 75 · see citing works
Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors
Deliganis, A. V., Pierce, P. A., & Peroutka, S. J. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90178-8 · Cited by 73 · see citing works
Earley, B., Burke, M. G., Leonard, B. E., Gouret, C.-J., & Junien, J. (1991) · Brain Research · doi:10.1016/0006-8993(91)91492-j · Cited by 68 · see citing works
Feltmann, K., Borroto‐Escuela, D. O., Rüegg, J., Pinton, L., de Oliveira Sergio, T., Narváez, M., Jimenez‐Beristain, A., Ekström, T. J., Fuxe, K., & Steensland, P. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13568 · Cited by 67 · see citing works
Sigma receptors are associated with cortical limbic areas in the primate brain
Mash, D. C., & Zabetian, C. P. (1992) · Synapse · doi:10.1002/syn.890120304 · Cited by 66 · see citing works
Small but sturdy: small RNAs in cellular memory and epigeneticsPreprint
Stuwe, E., Tóth, K. F., & Aravin, A. A. (2014) · Genes & Development · doi:10.1101/gad.236414.113 · Cited by 66 · see citing works
Modulation of voltage‐gated channel currents by harmaline and harmane
Splettstoesser, F., Bonnet, U., Wiemann, M., Bingmann, D., & Büsselberg, D. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706024 · Cited by 65 · see citing works
Requirement for BDNF in the Reconsolidation of Fear Extinction
Radiske, A., Rossato, J. I., Köhler, C. A., González, M. C., Medina, J. H., & Cammarota, M. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4093-14.2015 · Cited by 61 · see citing works
Sánchez‐Blázquez, P., Rodríguez-Muñoz, M., Herrero-Labrador, R., Burgueño, J., Zamanillo, D., & Garzón, J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000029 · Cited by 57 · see citing works
A mnemonic role for vasopressin: The evidence for and against
Strupp, B. J., & Levitsky, D. A. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90018-1 · Cited by 56 · see citing works
Fuxé, K., & Borroto‐Escuela, D. O. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.244 · Cited by 55 · see citing works
Balasuriya, D., D’Sa, L., Talker, R., Dupuis, E., Maurin, F., Martin, P., Borgèse, F., Soriani, O., & Edwardson, J. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.603506 · Cited by 54 · see citing works
Fuxé, K., & Borroto‐Escuela, D. O. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.189168 · Cited by 53 · see citing works
Recovery from amnesia induced by pre-test injections of monoamine oxidase inhibitors
Botwinick, C. Y., & Quartermain, D. (1974) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(74)90083-5 · Cited by 53 · see citing works
Tabei, K. (2015) · Behavioural Neurology · doi:10.1155/2015/529043 · Cited by 52 · see citing works
de Castro-Neto, E. F., da Cunha, R. H., da Silveira, D. X., Yonamine, M., Gouveia, T. L. F., Cavalheiro, É. A., Amado, D., & Naffah‐Mazzacoratti, M. D. G. (2013) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v4.i4.141 · Cited by 52 · see citing works
L-Type Voltage-Gated Calcium Channels in the Basolateral Amygdala Are Necessary for Fear Extinction
Davis, S. E., & Bauer, E. P. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0809-12.2012 · Cited by 51 · see citing works
PET Tracers for Serotonin Receptors and Their Applications
Kumar, J. S. D., & Mann, J. (2015) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524914666141030124316 · Cited by 48 · see citing works
Antonini, V., Prezzavento, O., Coradazzi, M., Marrazzo, A., Ronsisvalle, S., Arena, E., & Leanza, G. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06000.x · Cited by 48 · see citing works
Structure activity relationship of synaptic and junctional neurotransmission
Goyal, R. K., & Chaudhury, A. (2013) · Autonomic Neuroscience · doi:10.1016/j.autneu.2013.02.012 · Cited by 43 · see citing works
L-type voltage-gated calcium channels in conditioned fear: A genetic and pharmacological analysisPreprint
McKinney, B. C., Sze, W., White, J. A., & Murphy, G. G. (2008) · Learning & Memory · doi:10.1101/lm.893808 · Cited by 43 · see citing works
Updating stored memory requires adult hippocampal neurogenesis
Suárez‐Pereira, I., & Carrión, Á. M. (2015) · Scientific Reports · doi:10.1038/srep13993 · Cited by 42 · see citing works
Rau, V., Iyer, S. V., Oh, I., Chandra, D., Harrison, N. L., Eger, E. I., Fanselow, M. S., Homanics, G. E., & Sonner, J. M. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181bf6ae6 · Cited by 41 · see citing works
Ayahuasca as a Candidate Therapy for PTSD
Nielson, J. L., & Megler, J. D. (2013) · Springer eBooks · doi:10.1007/978-3-642-40426-9_3 · Cited by 40 · see citing works
Woodcock, E. A., White, R. T., & Diwadkar, V. A. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.050 · Cited by 39 · see citing works
Imaging dopamine neurotransmission in live human brain
Badgaiyan, R. D. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63425-2.00007-6 · Cited by 38 · see citing works
Lenart, L., Hodrea, J., Hosszú, Á., Kőszegi, S., Zelena, D., Balogh, D., Szkibinszkij, E., Veres-Székely, A., Wagner, L., Vannay, Á., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4209-x · Cited by 28 · see citing works
Urgesi, C., Mattiassi, A. D. A., Buiatti, T., & Marini, A. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.05.039 · Cited by 25 · see citing works
Kiese, K., Jablonski, J., Hackenbracht, J., Wrosch, J. K., Groemer, T. W., Kornhuber, J., Blümcke, I., & Kobow, K. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0485-x · Cited by 25 · see citing works
Beggiato, S., Borelli, A. C., Borroto‐Escuela, D. O., Corbucci, I., Tomasini, M. C., Marti, M., Antonelli, T., Tanganelli, S., Fuxé, K., & Ferraro, L. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.09.007 · Cited by 25 · see citing works
Temme, S. J., & Murphy, G. G. (2017) · Learning & Memory · doi:10.1101/lm.045773.117 · Cited by 24 · see citing works
Sigma-1 Receptor Agonists Directly Inhibit NaV1.2/1.4 Channels
Gao, X.-F., Yao, J.-J., He, Y., Hu, C., & Mei, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049384 · Cited by 21 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
de Vos, C. M. H., Mason, N. L., & Kuypers, K. P. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.724606 · Cited by 269 · see citing works
Reviewing the Potential of Psychedelics for the Treatment of PTSD
Krediet, E., Bostoen, T., Breeksema, J., van Schagen, A., Passie, T., & Vermetten, E. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa018 · Cited by 260 · see citing works
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232 · see citing works
Self-citationTreatment of Posttraumatic Stress Disorder: A State-of-the-art Review
Burback, L., Brémault‐Phillips, S., Nijdam, M. J., McFARLANE, A. C., & Vermetten, E. H. G. J. M. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230428091433 · Cited by 232 · see citing works
Almeida, R. N. D., Galvão, A. C. D. M., da Silva, F. S., Silva, E. A. D. S., Palhano-Fontes, F., Maia-de-Oliveira, J. P., de Araújo, L.-S. B., Lobão-Soares, B., & Galvão-Coelho, N. L. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.01234 · Cited by 177 · see citing works
The acute effects of classic psychedelics on memory in humans
Healy, C. J. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05756-w · Cited by 95 · see citing works
Bahji, A., Forsyth, A., Groll, D., & Hawken, E. R. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109735 · Cited by 88 · see citing works
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 85 · see citing works
Ruffell, S., Netzband, N., Tsang, W., Davies, M., Inserra, A., Butler, M., Rucker, J., Tófoli, L. F., Dempster, E. L., Young, A. H., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.687615 · Cited by 74 · see citing works
Self-citationCritical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy
Lepow, L., Morishita, H., & Yehuda, R. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.710004 · Cited by 73 · see citing works
Psychedelics as a novel approach to treating autoimmune conditions
Thompson, C., & Szabó, A. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.10.001 · Cited by 71 · see citing works
Raut, S. B., Marathe, P. A., van Eijk, L., Eri, R. D., Ravindran, M., Benedek, D. M., Ursano, R. J., Canales, J. J., & Johnson, L. R. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108195 · Cited by 71 · see citing works
Yang, K., Wang, C., & Sun, T. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00528 · Cited by 55 · see citing works
Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders
Lowe, H. I. C., Toyang, N., Steele, B., Grant, J. F., Ali, A., Gordon, L., & Ngwa, W. (2022) · Molecules · doi:10.3390/molecules27082520 · Cited by 50 · see citing works
The Pharmacology of Visual Hallucinations in Synucleinopathies
Russo, M., Carrarini, C., Dono, F., Rispoli, M. G., Pietro, M. D., Stefano, V. D., Ferri, L., Bonanni, L., Sensi, S. L., & ONOFRJ, M. C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01379 · Cited by 56 · see citing works
A Review of Epigenetics of PTSD in Comorbid Psychiatric Conditions
Blacker, C. J., Frye, M. A., Morava, É., Kozicz, T., & Veldić, M. (2019) · Genes · doi:10.3390/genes10020140 · Cited by 56 · see citing works
Exploring DMT: Endogenous role and therapeutic potential
Schimmelpfennig, J., & Jankowiak-Siuda, K. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110314 · Cited by 54 · see citing works
An introduction to psychedelic neuroscience
Calvey, T., & Howells, F. M. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.09.013 · Cited by 49 · see citing works
The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology
Mastinu, A., Anyanwu, M., Carone, M., Abate, G., Bonini, S. A., Peron, G., Tirelli, E., Pucci, M., Ribaudo, G., Oselladore, E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021329 · Cited by 49 · see citing works
The pharmacological interaction of compounds in ayahuasca: a systematic review
Ruffell, S., Netzband, N., Bird, C., Young, A. H., & Juruena, M. F. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-0884 · Cited by 45 · see citing works
Kelley, D. P., Venable, K., Destouni, A., Billac, G., Ebenezer, P., Stadler, K., Nichols, C., Barker, S., & Francis, J. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00660 · Cited by 42 · see citing works
Levin, M. G. (2024) · Entropy · doi:10.3390/e26060481 · Cited by 44 · see citing works
Inserra, A., Campanale, A., Cheishvili, D., Dymov, S., Wong, A. H. Y., Marçal, N., Syme, R. A., Taylor, L., Gregorio, D. D., Kennedy, T. E., et al. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110594 · Cited by 41 · see citing works
Self-citationN,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine
James, E., Keppler, J., Robertshaw, T. L., & Sessa, B. (2022) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2835 · Cited by 43 · see citing works
Healy, C. J., Lee, K. A., & D'Andrea, W. M. (2021) · Chronic Stress · doi:10.1177/24705470211029881 · Cited by 38 · see citing works
Barsuglia, J. P., Polanco, M., Palmer, R., Malcolm, B. J., Kelmendi, B., & Calvey, T. (2018) · Progress in Brain Research · doi:10.1016/bs.pbr.2018.08.002 · Cited by 38 · see citing works
Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential
Allen, J., Dames, S., Foldi, C. J., & Shultz, S. R. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02360-0 · Cited by 38 · see citing works
Levin, M. (2025) · BioEssays · doi:10.1002/bies.202400196 · Cited by 34 · see citing works
Borbély, E., Varga, V. É., Szögi, T., Schuster, I., Bozsó, Z., Penke, B., & Fülöp, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052514 · Cited by 34 · see citing works
Rossi, G. N., Guerra, L. T. L., Baker, G. B., Dursun, S. M., Bouso, J. C., Hallak, J. E. C., & SANTOS, R. G. D. (2022) · Biomolecules · doi:10.3390/biom12111618 · Cited by 33 · see citing works
A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics
Banushi, B., & Polito, V. (2023) · Biology · doi:10.3390/biology12111380 · Cited by 25 · see citing works
Santos, B. W. L., Moreira, D. C., Borges, T. K. D. S., & Caldas, E. D. (2022) · Molecules · doi:10.3390/molecules27082500 · Cited by 30 · see citing works
The potential of psychedelics for the treatment of Alzheimer's disease and related dementias
Winkelman, M., Szabó, A., & Frecska, E. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.07.003 · Cited by 27 · see citing works
Epigenetic Mechanisms of Rapid-Acting Antidepressants
Inserra, A., Campanale, A., Rezai, T., Romualdi, P., & Rubino, T. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03055-y · Cited by 27 · see citing works
Self-citationPadawer-Curry, J. A., Krentzman, O. J., Kuo, C., Wang, X., Bice, A. R., Nicol, G. E., Snyder, A. Z., Siegel, J. S., McCall, J. G., & Bauer, A. Q. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02069-z · Cited by 28 · see citing works
Epigenetic Echoes: Bridging Nature, Nurture, and Healing Across Generations
Banushi, B., Collova, J. R., & Milroy, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073075 · Cited by 27 · see citing works
Goldpaugh, D. D. (2021) · Sexual & Relationship Therapy · doi:10.1080/14681994.2021.1994138 · Cited by 22 · see citing works
da Silva, M. G., Daros, G. C., & de Bitencourt, R. M. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113003 · Cited by 22 · see citing works
Callon, C., Williams, M., & Lafrance, A. (2021) · Journal of Humanistic Psychology · doi:10.1177/00221678211043300 · Cited by 21 · see citing works
Werle, I., & Bertoglio, L. J. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105899 · Cited by 23 · see citing works
Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability
Rossi, G. N., Dias, I. C. D. S., Baker, G. B., Bouso, J. C., Dursun, S. M., Hallak, J. E. C., & SANTOS, R. G. D. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2054988 · Cited by 21 · see citing works
Ayahuasca and Dimethyltryptamine Adverse Events and Toxicity Analysis: A Systematic Thematic Review
White, E., Kennedy, T., Ruffell, S., Perkins, D., & Sarris, J. J. (2024) · International Journal of Toxicology · doi:10.1177/10915818241230916 · Cited by 21 · see citing works
Nogueira, M., Golbert, D. C. F., de Menezes, R. S. T., de Almeida, R. N., Coelho, N. L. G., Siroky, A. N., Lima, T. Z., Maia, H., Leão, K. E., & Leão, R. N. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02655-w · Cited by 20 · see citing works
Campanale, A., Inserra, A., & Comai, S. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111058 · Cited by 18 · see citing works
Self-citationInserra, A., Piot, A., Gregorio, D. D., & Gobbi, G. (2023) · CNS Drugs · doi:10.1007/s40263-023-01008-5 · Cited by 17 · see citing works
Self-citationEvidence on the impairing effects of Ayahuasca on fear memory reconsolidation
Daneluz, D. M., Sohn, J. M. B., Silveira, G. D. O., Yonamine, M., & Stern, C. A. J. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06217-2 · Cited by 16 · see citing works
Sanabria, E. (2021) · BioSocieties · doi:10.1057/s41292-020-00222-4 · Cited by 16 · see citing works
PTSD as an Endothelial Disease: Insights From COVID-19
Sfera, A., Osorio, C. P., Rahman, L., del Campo, C. M. Z.-M., Maldonado, J. C., Jafri, N., Cummings, M. A., Maurer, S., & Kozlakidis, Z. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.770387 · Cited by 16 · see citing works
Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters
Jahanabadi, S., Amiri, S., Karkeh-abadi, M., & Razmi, A. (2023) · Fitoterapia · doi:10.1016/j.fitote.2023.105620 · Cited by 14 · see citing works
Psychedelics and autobiographical memory – six open questions
Kangaslampi, S., & Lietz, M. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06771-5 · Cited by 10 · see citing works
Beretta, E., Cuboni, G., & Deidda, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125508 · Cited by 12 · see citing works
Psychoactive substances for the treatment of neuropsychiatric disorders
Zhen, Z., Sun, X., Yuan, S., & Zhang, J. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104193 · Cited by 9 · see citing works
Hilal, F. F., Jeanblanc, J., Deschamps, C., Naassïla, M., Pierrefiche, O., & Hamida, S. B. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02757-3 · Cited by 8 · see citing works
Freeman, J., Salberg, S., Noel, M. E., & Mychasiuk, R. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03267-w · Cited by 6 · see citing works
Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy
Lepow, L., Morishita, H., & Yehuda, R. (2023) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.23021012 · Cited by 8 · see citing works
The Effects of Ayahuasca on Psychological Disorders: A Systematic Literature Review
Sheth, R., Parikh, E., Olayeye, K., Pfeifer, K., & Khanna, D. (2024) · Cureus · doi:10.7759/cureus.55574 · Cited by 8 · see citing works
Levin, M. G. (2024) · doi:10.31219/osf.io/yq9xe · Cited by 5 · see citing works
Clinical pharmacology of ayahuasca: potential applications and future considerations
Guerra, L. T. L., Dias, I. C. D. S., Hallak, J. E. C., & SANTOS, R. G. D. (2025) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2025.2577726 · Cited by 3 · see citing works
Epigenetics of neural networks in neurocognitive conditions: A review
Stolberg, V. B. (2025) · Brain Network Disorders · doi:10.1016/j.bnd.2025.08.001 · Cited by 3 · see citing works
A Qualitative Assessment of Risks and Benefits of Ayahuasca for Trauma Survivors
Nielson, J. L., Megler, J. D., & Cavnar, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_5 · Cited by 3 · see citing works
Effects of ayahuasca on fear and anxiety: cross-talk between 5HT1A and 5HT2A receptors
Guerra, L. T. L., dos Santos, R. D., & Hallak, J. E. C. (2024) · Psychedelics · doi:10.61373/pp024i.0037 · Cited by 2 · see citing works
Schimmelpfennig, J., & Jankowiak-Siuda, K. (2023) · Neuropsychiatria i Neuropsychologia · doi:10.5114/nan.2023.129068 · Cited by 2 · see citing works
Paulus, S. (2023) · Philosophies · doi:10.3390/philosophies9010007 · Cited by 2 · see citing works
Batalla, M. (2023) · Science Reviews Biology · doi:10.57098/scirevs.biology.2.2.1 · Cited by 2 · see citing works
Haupt, M. J., Carra, S., Boehnke, K. F., & Aday, J. S. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111634 · Cited by 2 · see citing works
Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland
Kelly, J. R., Sheridan, C., Iusan, P., Coakley, L., Burke, L., Brennan, C., MacDonald, A. A., Ivers, J., Trépel, D., Tormey, G., et al. (2026) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyag028 · Cited by 1 · see citing works
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_141-1 · Cited by 1 · see citing works
Self-citationGreene, S. L. (2025) · Comprehensive analytical chemistry · doi:10.1016/bs.coac.2024.12.002 · Cited by 1 · see citing works
Novel harmala-ocudelic tuning (HOT) for ocular disorders
Lansky, E. S. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109834 · Cited by 1 · see citing works
Understanding the Regulation of Transcription in Mental Illness
O’Sullivan, S. J. (2021) · OBM Genetics · doi:10.21926/obm.genet.2104143
Schimmelpfennig, J., & Jankowiak-Siuda, K. (2023) · Pharmacotherapy in Psychiatry and Neurology · doi:10.5114/fpn.2023.131979
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_141-2
Self-citationMedical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_141
Self-citationMaeder, S., Fahim, C., & Martin-Söelch, C. (2025) · Cortica · doi:10.26034/cortica.2025.8925
The Effects of Psychedelics on Repressed Memory: A Scoping Review
Kooman, L., Griesfeller, A.-F., Henry, & Kloft, L. (2024) · Open Science Framework · doi:10.17605/osf.io/tdcxk
Ayahuasca, DMT, and Mental Health: A Current Review of Scientific Studies
Araújo, D. B., Maia, L. O., Sanchez, T. A., Coelho, N. L. G., & Palhano-Fontes, F. (2026) · Current Addiction Reports · doi:10.1007/s40429-026-00721-7
Gojani, E. G., Farzin, H., Sutherland, R. J., & Mohajerani, M. H. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106619
INTERVENTIONS AND TREATMENT FOR THE EFFECTS OF ACEs
Riley, D., & Pates, R. M. (2026) · doi:10.1002/9781394282432.ch13
Anything that helps: cancer patient and carer perspectives on psychedelic-assisted therapy
Wech, A., Akroyd, A., Clayden, C., & Reynolds, L. M. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10693-z
Pivotal physical states: The somatic equivalent to pivotal mental states
Uthaug, M. V., Allocca, J. G., Havenith, M. N., Szabó, A., Rosas, F. E., Mason, N. L., Hargraves, H., & Ramaekers, J. G. (2026) · Journal of Psychedelic Studies · doi:10.1556/2054.2026.00482
Cellular mechanisms of serotonergic psychedelics - apical hypercontextualisation
Kaup, K., Jiménez, J. H., & Aru, J. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106876
Xiang, A. Q., Thalmann, M., Khanna, I., Harish, S., Khanna, M., Kulkarni, A., & Chen, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1829506
Civardi, S. C., Besana, F., Durbano, F., Toscano, M. O. M., Raffone, F., Dell’Osso, B. M., & Olivola, M. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1858319
- Authors
- Inserra, A.
- Affiliations
- Flinders University (AU)
- Corresponding author
- Inserra, Antonio
- ORCID
- Inserra, Antonio
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-04-05
- Volume
- 9
- Pages
- 330-330
- ISSN
- 1663-9812 (ISSN-L)
- PMC
- PMC5895707
- OpenAlex
- W2794934757
- Cited by
- 91
- References
- 131
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 16 · 2023: 14 · 2022: 11 · 2021: 13 · 2020: 9 · 2019: 5 · 2018: 2 · 2012: 1
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Pharmacology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Flinders Academic Commons (Flinders University) (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pharmacological Receptor Mechanisms and Effects
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Keywords
- ayahuasca, dimethyltryptamine, sigma-1 receptor, monoamine oxidase inhibitors, post-traumatic stress disorder, traumatic memory, memory reconsolidation, fear extinction, synaptic plasticity, epigenetic modulation, anti-amnesic effect, memory retrieval, neuroimmunomodulation, psychedelic therapy, neurogenesis, dopamine signaling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review